+91 84258 80640 export@saliuspharma.com

Product Overview

Itraconazole Immediate Release (IR) Pellets are formulated to provide fast and efficient antifungal action by promoting rapid dissolution and absorption of Itraconazole—a broad-spectrum triazole antifungal agent. Designed to overcome the compound’s poor solubility, these pellets are manufactured using optimized layering and coating techniques to enhance bioavailability and gastrointestinal absorption.

Acetaminophen DC Granules – Typical Composition

Component Function
Itraconazole Active Pharmaceutical Ingredient (API)
Sugar Spheres / MCC Pellets Inert core / Neutral starter spheres
Hydroxypropyl Methylcellulose (HPMC) Binder / Film former for drug layering
Polysorbate 80 / Sodium Lauryl Sulfate (SLS) Wetting agent / Solubilizer to enhance dissolution
PEG 6000 / PVP K30 Solubilizer / Stabilizer for improved dispersion
Talc / Colloidal Silicon Dioxide Anti-adherent / Glidant
Purified Water Solvent (evaporated during processing)

Why Choose Pellets from Salius Pharma?

Salius Pharma offers Itraconazole IR Pellets manufactured in USFDA-approved, WHO-GMP, and ISO-certified facilities in India, ensuring adherence to the highest global quality and regulatory standards. Our pellets are formulated using advanced layering and solubilization technologies to enhance bioavailability and provide consistent immediate release. Available in customizable strengths and pellet sizes.

Key Advantages of Partnering with Salius Pharma

Expected Delivery Time

We ensure prompt and reliable shipping worldwide. Delivery times may vary depending on destination, order volume, and regulatory requirements.

Place an Order or Request a Quote from Salius Pharma

Looking to source Itraconazole IR Pellets or other high-quality pharmaceutical pellet formulations?
Whether you need Active Pharmaceutical Ingredients (APIs), excipients, or regulatory support, our team is ready to provide reliable, compliant, and cost-effective solutions tailored to your market needs.

Get in Touch

Confidentiality Notice

The contents of this page and any attachments are intended solely for the designated recipient(s) and may contain confidential and/or privileged information protected by law.

Any patented products are excluded from our offerings in regions where such patents are currently in force.

FAQs

The pelletized immediate-release formulation offers uniform dosing and improved stability, making it easier to incorporate into oral capsules or sachets, which simplifies administration for patients.

Salius Pharma utilizes advanced layering and coating techniques combined with validated HPLC methods to ensure consistent potency, stability, and rapid drug release.

Yes, we provide tailored regulatory support including preparation of documentation compliant with USP, BP, and EP standards to facilitate market approval in diverse global regions.

Send Enquiry
Chat With Us!
Call Us!
Mail Us!